x 

0 Activities
0 Activities
    • No Saved Activities

Education

  2. Home
  3. Disease Area
  4. Alpha-1 Antitrypsin Deficiency (AATD)
  5. Specialty Area
  6. Internal Medicine
Page 2 of 3
Results 151 - 300 of 302
No image set
First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology
No image set
Characterisation of Adeno-Associated Virus Vector Persistence
No image set
Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a)
No image set
Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Drygalski)
No image set
Efficacy and Safety of Etranacogene Dezaparvovec in Adults
No image set
COVID-19 Associated ARDS
No image set
COVID-19 and Comorbid ILD
No image set
Three Cases of Lung Fibrosis in Patients With COVID-19
No image set
Nutritional Treatment Plan
No image set
Nutritional Counseling
No image set
Are your decisions influenced by thrilling headlines?
No image set
Are the decisions you made today based on the experiences you had yesterday?
No image set
Are your decisions impacted by what’s expected of you?
No image set
COVID-19 Acute and Long-term Lung Injury
No image set
COVID-19: An Animated Video Series
No image set
Rheumatic Learning: Next Steps for Mr. S's Established RA
No image set
Rheumatic Learning: Next Steps for Mrs. J's Early RA
No image set
Rheumatic Learning: How Can You Help Jeff With His Psoriatic Arthritis?
No image set
Rheumatic Learning: How can you help Andrea with her Psoriatic Arthritis?
No image set
COVID-19 and ARDS: East Coast Experiences
obesity-self-guided
Obesity: Self-Guided Patient Case
No image set
Bone Disease: Self-Guided Patient Case
No image set
Contemporary Topics in RCC: Tumor Board
No image set
Lipids: Self-Guided Patient Case
No image set
Type 2 Diabetes: Self-Guided Patient Case
No image set
Exploring CGM: Essentials for Primary Care
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan to Manage IPF
No image set
Diagnosis of Interstitial Lung Disease
No image set
Learnings From the Virtual ERS International Congress
No image set
Practical Questions in the Diagnosis and Management of Patients With MAC
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Nutrition Screening and Testing
No image set
Hereditary Transthyretin Amyloidosis: Case Studies
No image set
Understanding Lysosomal Storage Disorders
No image set
hATTR Amyloidosis: You and Your Family
No image set
The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring
No image set
The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence
9165 product
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
No image set
Applying Principles of Pain Management
No image set
Patient Case: Osteoarthritis (OA) of the Knee
No image set
Patient Case: Lower Back Pain
No image set
Gene Therapy for Treatment of Hemophilia: AAV Vector Gene Therapy Application to Hemophilia
No image set
Advances in Multiple Sclerosis (AIMS) Primer: 3rd Edition
What's New in Advanced CSCC Care
New Paradigms in the Management of Locally Advanced or Metastatic CSCC
What's New in Advanced CSCC Care
The Evidence So Far: Risk, Referral, and What's New in Advanced CSCC Care
No image set
Lipids: Successful Co-management between Primary Care and Endocrinology
No image set
Bone/Thyroid: Successful Co-management between Primary Care and Endocrinology
No image set
Obesity: Successful Co-management between Primary Care and Endocrinology
No image set
Diabetes: Successful Co-management between Primary Care and Endocrinology
No image set
Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Vector Gene Transfer
No image set
SMA Updates from Around the World
No image set
Gene Therapy for Treatment of Hemophilia: Other Strategies and Targets
No image set
A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting
9840-0004-icon
Acute Exacerbations of IPF
No image set
Gene Therapy for Treatment of Hemophilia: Common Concerns in Gene Therapy
9916-cme-icon
Personalized Medicine for Improving Asthma Care: An Animated Video Series
9815-developments
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9815-palliative slides
Palliative Medicine in Pulmonology
9916-0005-icon
Discussions with Patients to Optimize Asthma Control
9916-0004_treatment
Who Should be Targeted For Treatment With Biologic Therapy?
9916-0003_endotypes
Endotypes and Phenotypes in Asthma
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9916-0001_meds
Approved Medications for the Treatment of Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics?
9916-brown5
The Impact of Anticoagulation Use on IPF Patient Outcomes
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
9840-glassberg2
Evaluation and Diagnosis of IPF
9840-glassberg1
Initial Treatment Decisions of IPF
9837-coolidge
What if President Calvin Coolidge Was Your Asthma Patient?
9840-0003
Optimizing Management of IPF
9916-king
What are the Most Exciting Things Happening in Pulmonary Disease?
9837-roosevelt
How Would You Manage President Theodore Roosevelt’s Asthma Today?
9916-scholand
New Tools to Improve the Diagnosis of IPF vs Other ILDs
9916-brown
New Research on Therapies for Patients with Pulmonary Fibrosis
9916-richeldi
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
9916-cc-cme
2019 Summer Pulmonary Updates: The Experts Weigh In
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
med-doc-aatd
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
med-doc-ph
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
hopa-icon8
Biosimilars: Applying the Science to Hematology/Oncology Practice
9816-0001
The Latest from a Recent Pulmonary Conference in San Antonio
9816-0010
Updates in Inoperable CTEPH
9816-0009
The Importance of Early Integration of Palliative Care
9816-0006
Management of IPF Patients in 2018
9816-0005
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
9816-00045
Overview of the Latest Clinical Trials in IPF
9816-0003
Evolution of Antifibrotic Therapy in IPF
9816-0002
Take Home Messages from the 2018 CHEST Annual Meeting
9816-0008
What We’re Learning from the IPF-PRO Registry
9816-0007
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
atopic-derm4
Atopic Dermatitis: Putting it Together (Dermatology)
atopic-derm3
Atopic Dermatitis: Putting it Together (Primary Care)
atopic-derm2 copy
Atopic Dermatitis: Recent and Emerging Therapies
atopic-derm1
An Introduction to Atopic Dermatitis
9808-0003
SMA Updates from Los Angeles
pah icon
PAH Today: Mastering Current, Tailored Treatment
No image set
Achieving Better Control of Severe Asthma
asthma-uncontrol icon
A Personalized Approach to Managing Uncontrolled Asthma
9808-0002
Updates in SMA and Gene Therapy from Arlington, VA
Proper_Use_of_an_Inhaler_264x150
Proper Use of an Inhaler
psoriasis-nurse
Psoriasis Management Considerations: What Would You Do?
psoriasis-case3
Jamie Develops Complications with Her Psoriasis
psoriasis-case2
Psoriasis: Three Case Studies in the Primary Care Setting
psoriasis-case1
Cindy Has a Complex Case of Psoriasis
9707-ella
Famous People with Diabetes: Ella Fitzgerald
9707-jerry
Famous People with Diabetes: Jerry Garcia
aims icon-target
Targeting B-cells in Primary Progressive MS (PPMS)
aims icon-comorb
Comorbidities and Selection of DMTs
aims icon-gut
The Gut Microbiota in MS
aims icon-early
Early MS: Induction Therapy and Escalation Strategies
aims icon-vitamin
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
t2diabetes-slides1
Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options
t2diabetes-slides2
Download Slides: Advancing T2DM Therapy with Confidence
t2diabetes-louise
Getting to Goal Can Be Difficult: Louise
t2diabetes-brian
Getting to Goal Can Be Difficult: Brian
IL-rheum-case3
Considering Biosimilars in Patients Failing their Initial Biologic
IL-rheum-case2
When to Switch? Biologically Experienced Patients with Spondyloarthritis
IL-rheum-case1
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
IL-gastro-case3
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
IL-gastro-case2
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
IL-gastro-case1
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
IL-derm-case3
Switching Between Biologics: Is a Biosimilar an Option?
IL-derm-case2
When to Switch? Biologically Experienced Psoriasis Patients
IL-derm-case1
Innovator or Biosimilar for a Patient with Psoriasis
IL-fund-case4
Interchangeability and Pharmacy-Level Substitution
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
biosims-full
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
biosims-green5
Are You Ready to Use Biosimilars in Your Practice?
biosims-full3
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
biosims-green3
Pharmacovigilance and Biosimilars: Any Special Considerations?
biosims-full5
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
biosims-green8
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
biosims-full7
Biosimilars: As Safe and Effective as the Reference Product?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
Page 2 of 3

Search